Literature DB >> 19893455

A case of IgG4-related sclerosing disease with retroperitoneal fibrosis, autoimmune pancreatitis and bilateral focal nephritis.

Wouter Van Moerkercke1, Marc Verhamme, Gert Meeus, Raymond Oyen, Werner Van Steenbergen.   

Abstract

A 74-year-old male patient presented with progressive anorexia, cholestatic liver function tests, and a diffuse enlarged pancreas suggestive of a pancreatic carcinoma. There was a marked elevation of total immunoglobulin G4 (IgG4) in serum. Further investigation led to the diagnosis of IgG4-related sclerosing disease with involvement of the pancreas, retroperitoneal fibrosis, and bilateral focal nephritis. To our knowledge, this is the first report on these 3 clinical entities occurring in the same patient.A short review of the literature concerning autoimmune pancreatitis and retroperitoneal fibrosis is made, with special interest to the concept of IgG4-related pathology. This systemic disease can have several clinical manifestations: IgG4-positivity not only can be found in the pancreas, but also at the level of extrahepatic biliary ducts, gallbladder, salivary glands, retroperitoneal tissue, kidneys, ureters, and lymph nodes. Although further investigation is required to determine its exact pathophysiologic role, IgG4 seems to be an important key player.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19893455     DOI: 10.1097/MPA.0b013e318ac522f

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  2 in total

1.  Immunoglobulin g4-related systemic sclerosing disease: a case involving the ureter and kidney.

Authors:  Sunchan Kim; Tae Gu Kim; Seung-Kwon Choi; Myung Joon Kim; Gyeong Eun Min; Hyung-Lae Lee; Koo Han Yoo
Journal:  Korean J Urol       Date:  2013-03-15

2.  Autoimmune Disease Classification Based on PubMed Text Mining.

Authors:  Hadas Samuels; Malki Malov; Trishna Saha Detroja; Karin Ben Zaken; Naamah Bloch; Meital Gal-Tanamy; Orly Avni; Baruh Polis; Abraham O Samson
Journal:  J Clin Med       Date:  2022-07-26       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.